These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34755605)

  • 1. In situ gel implant for postsurgical wound management and extended chemoimmunotherapy against breast cancer recurrence.
    Wang M; Wang S; Pan Y; Yu R; Zhang ZR; Fu Y
    Acta Biomater; 2022 Jan; 138():168-181. PubMed ID: 34755605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic platelet inhibition with localized chemotherapy by an injectable ROS-scavenging gel against postsurgical breast cancer recurrence and metastasis.
    Gui J; Zhu Y; Chen X; Gong T; Zhang Z; Yu R; Fu Y
    Acta Biomater; 2024 Mar; 177():388-399. PubMed ID: 38307476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable Zwitterionic Physical Hydrogel with Enhanced Chemodynamic Therapy and Tumor Microenvironment Remodeling Properties for Synergistic Anticancer Therapy.
    Fang Y; Huang S; Hu Q; Zhang J; King JA; Wang Y; Wei Z; Lu J; He Z; Kong X; Yang X; Ji J; Li J; Zhai G; Ye L
    ACS Nano; 2023 Dec; 17(24):24883-24900. PubMed ID: 37883579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers.
    Kashani B; Zandi Z; Karimzadeh MR; Bashash D; Nasrollahzadeh A; Ghaffari SH
    Immunol Res; 2019 Dec; 67(6):505-516. PubMed ID: 32026322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR4 Blockade Using Docosahexaenoic Acid Restores Vulnerability of Drug-Tolerant Tumor Cells and Prevents Breast Cancer Metastasis and Postsurgical Relapse.
    Wang M; Wang Y; Liu R; Yu R; Gong T; Zhang Z; Fu Y
    ACS Bio Med Chem Au; 2023 Feb; 3(1):97-113. PubMed ID: 37101603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-loaded implantable surgical cavity-adaptive hydrogels for prevention of local tumor recurrence.
    Zhuang B; Chen T; Xiao Z; Jin Y
    Int J Pharm; 2020 Mar; 577():119048. PubMed ID: 31978462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment-labile polymer-doxorubicin conjugate thermogel combined with docetaxel for in situ synergistic chemotherapy of hepatoma.
    Zhang Y; Zhang J; Xu W; Xiao G; Ding J; Chen X
    Acta Biomater; 2018 Sep; 77():63-73. PubMed ID: 30006312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferritin-Based Nanocomposite Hydrogel Promotes Tumor Penetration and Enhances Cancer Chemoimmunotherapy.
    Liu R; Liang Q; Luo JQ; Li YX; Zhang X; Fan K; Du JZ
    Adv Sci (Weinh); 2024 Jan; 11(3):e2305217. PubMed ID: 38029345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polydopamine-doped supramolecular chiral hydrogels for postoperative tumor recurrence inhibition and simultaneously enhanced wound repair.
    Wang X; Wu B; Zhang Y; Dou X; Zhao C; Feng C
    Acta Biomater; 2022 Nov; 153():204-215. PubMed ID: 36108967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-situ nanoplatform with synergistic neutrophil intervention and chemotherapy to prevent postoperative tumor recurrence and metastasis.
    Zheng W; Li J; Li J; Bie N; Wei Z; Qin J; Li S; Yong T; Du Q; Yang X; Gan L
    J Control Release; 2024 Nov; 375():316-330. PubMed ID: 39251139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zwitterionic Injectable Hydrogel-Combined Chemo- and Immunotherapy Medicated by Monomolecular Micelles to Effectively Prevent the Recurrence of Tumor Post Operation.
    Wang R; Hu Q; Huang S; Fang Y; Kong X; Kaur P; Zhang J; Wang Y; Liu D; Wu H; Li Y; Ji J; Yang X; Ye L; Zhai G
    ACS Appl Mater Interfaces; 2024 Jan; 16(3):4071-4088. PubMed ID: 38194589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Microenvironment-Triggered Charge Reversal Polymetformin-Based Nanosystem Co-Delivered Doxorubicin and IL-12 Cytokine Gene for Chemo-Gene Combination Therapy on Metastatic Breast Cancer.
    Sun Y; Liu L; Zhou L; Yu S; Lan Y; Liang Q; Liu J; Cao A; Liu Y
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):45873-45890. PubMed ID: 32924511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequentially sustained release of anticarcinogens for postsurgical chemoimmunotherapy.
    Chen Q; Li Y; Zhou S; Chen D; Zhou M; Chen Q; Lu Y; Cai N; Liu C; Guo Y; Qiu Z; Hou X; Tu J; Shen W; Sun C
    J Control Release; 2022 Oct; 350():803-814. PubMed ID: 36087802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
    Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
    Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Acting Nanohybrid Hydrogel Induces Persistent Immunogenic Chemotherapy for Suppressing Postoperative Tumor Recurrence and Metastasis.
    Li Y; Zhu J; Yang Y; Chen Y; Liu L; Tao J; Chen H; Deng Y
    Mol Pharm; 2023 Dec; 20(12):6345-6357. PubMed ID: 37942616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anticancer effect of the TLR4 inhibition using TAK-242 (resatorvid) either as a single agent or in combination with chemotherapy: A novel therapeutic potential for breast cancer.
    Zandi Z; Kashani B; Bashash D; Poursani EM; Mousavi SA; Chahardoli B; Ghaffari SH
    J Cell Biochem; 2020 Feb; 121(2):1623-1634. PubMed ID: 31535397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin-Loaded In Situ Gel Combined with Biocompatible Hydroxyethyl Cellulose Hemostatic Gauze for Controlled Release of Drugs and Prevention of Breast Cancer Recurrence Postsurgery.
    Yan BY; Liu BL; Yi LY; Wang GL; Xue BZ; Xie Y
    ACS Biomater Sci Eng; 2020 Oct; 6(10):5959-5968. PubMed ID: 33320580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer.
    Cao D; Zhang X; Akabar MD; Luo Y; Wu H; Ke X; Ci T
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):181-191. PubMed ID: 30686051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bio-responsive, cargo-catchable gel for postsurgical tumor treatment via ICD-based immunotherapy.
    Chen Q; Zhou S; Ding Y; Chen D; Dahiru NS; Tang H; Xu H; Ji M; Wang X; Li Z; Chen Q; Li Y; Tu J; Sun C
    J Control Release; 2022 Jun; 346():212-225. PubMed ID: 35461965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.